These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 19275634)

  • 21. Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-β Transport: A Population-Based Cross-Sectional Study.
    Wei S; Shang S; Dang L; Gao F; Gao Y; Gao L; Chen C; Huo K; Wang J; Wang J; Qu Q
    J Alzheimers Dis; 2021; 84(1):303-314. PubMed ID: 34542070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
    Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
    J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
    Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
    Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
    Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
    Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
    Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.
    Deane R; Wu Z; Zlokovic BV
    Stroke; 2004 Nov; 35(11 Suppl 1):2628-31. PubMed ID: 15459432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
    Zlokovic BV
    Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
    Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
    Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
    P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
    Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of amyloid-beta by circulating lipoprotein receptors.
    Sagare A; Deane R; Bell RD; Johnson B; Hamm K; Pendu R; Marky A; Lenting PJ; Wu Z; Zarcone T; Goate A; Mayo K; Perlmutter D; Coma M; Zhong Z; Zlokovic BV
    Nat Med; 2007 Sep; 13(9):1029-31. PubMed ID: 17694066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
    Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
    Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
    Wan W; Chen H; Li Y
    Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
    Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD
    Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.
    Jaeger LB; Dohgu S; Hwang MC; Farr SA; Murphy MP; Fleegal-DeMotta MA; Lynch JL; Robinson SM; Niehoff ML; Johnson SN; Kumar VB; Banks WA
    J Alzheimers Dis; 2009; 17(3):553-70. PubMed ID: 19433890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
    Jeynes B; Provias J
    Curr Alzheimer Res; 2008 Oct; 5(5):432-7. PubMed ID: 18855584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.